+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro synergy studies based on tazobactam/piperacillin against clinical isolates of metallo-beta-lactamase-producing Pseudomonas aeruginosa

In vitro synergy studies based on tazobactam/piperacillin against clinical isolates of metallo-beta-lactamase-producing Pseudomonas aeruginosa

Journal of Antimicrobial ChemoTherapy 64(5): 1115-1116

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053777071

Download citation: RISBibTeXText

PMID: 19744981

DOI: 10.1093/jac/dkp333

Related references

In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates. Antimicrobial Agents and ChemoTherapy 54(9): 3625-3629, 2010

Comparative in-vitro activity of piperacillin and piperacillin plus tazobactam towards beta-lactamase producing clinical isolates. Journal of ChemoTherapy 2(5): 295-299, 1990

Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosa. ChemoTherapy 43(3): 171-178, 1997

Piperacillin with and without tazobactam against extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa in a rat thigh abscess model. ChemoTherapy 47(4): 292-296, 2001

Piperacillin with and without Tazobactam against Extended-Spectrum Beta-Lactamase-Producing Pseudomonas aeruginosa in a Rat Thigh Abscess Model. Chemotherapy 47(4): 292-296, 2001

Prevalence and detection of metallo-beta-lactamase (MBL)-producing Pseudomonas aeruginosa strains from clinical isolates in Iran. Annals of Microbiology 57(2): 293-295, 2007

Superior Effect of Tazobactam/ Piperacillin Compared to Piperacillin on -Lactamase-Producing Pseudomonas aeruginosa. Chemotherapy 43(3): 171-178, 1997

Evaluation of dipicolinic acid for detection of IMP- or VIM- type metallo-beta-lactamase-producing Pseudomonas aeruginosa clinical isolates. Diagnostic Microbiology and Infectious Disease 53(3): 241-244, 2005

Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital. Pathologie-Biologie 57(7-8): 530-535, 2009

Synergistic effect of polyethylenimine plus piperacillin/tazobactam on clinical Pseudomonas aeruginosa isolates resistant to piperacillin/tazobactam. Annals of Microbiology 56(4): 345-348, 2006

In vitro activity of tazobactam and piperacillin combination against 224 strains of Pseudomonas aeruginosa according to the production of beta-lactamase. Pathologie-Biologie 39(5): 361-366, 1991

Antibacterial activity of piperacillin and tazobactam against beta-lactamase-producing clinical isolates. ChemoTherapy 36(5): 356-364, 1990

Comparison of four antimicrobial susceptibility testing methods to determine the in vitro activities of piperacillin and piperacillin-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa. Journal of Clinical Microbiology 41(7): 3339-3343, 2003

In vitro susceptibility of multi-drug resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from clinical specimens at Bugando Medical Centre, Tanzania to Piperacillin-Tazobactam. Tanzania Journal of Health Research 16(1): 54-57, 2014

Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia. Diagnostic Microbiology and Infectious Disease 64(4): 458-461, 2009